A novel ,8-lactamase inhibitor has been isolated from Streptomyces clavuligerus ATCC 27064 and given the name clavulanic acid. Conditions for the cultivation of the organism and detection and isolation of clavulanic acid are described. This compound resembles the nucleus of a penicillin but differs in having no acylamino side chain, having oxygen instead of sulfur, and containing a (3-hydroxyethylidine substituent in the oxazolidine ring. Clavulanic acid is a potent inhibitor of many 8-lactamases, including those found inEscherichia coli (plasmid mediated), Klebsiella aerogenes, Proteus mirabilis, and Staphylococcus aureus, the inhibition being ofa progressive type. The cephalosporinase type of /8-lactamase found in Pseudomonas aeruginosa and Enterobacter cloacae P99 and the chromosomally mediated (8-lactamase ofE. coli are less well inhibited. The minimum inhibitory concentrations of ampicillin and cephaloridine against ,8-lactamase-producing, penicillin-resistant strains of S. aureus, K. aerogenes, P. mirabilis, and E. coli have been shown to be considerably reduced by the addition of low concentrations of clavulanic acid.
Streptomyces clavuligerus ATCC 27064 (NRRL 3585) has been described as producing several antibiotics structurally related to cephalosporin C, namely, the 3-carbamoyloxymethyl analogue, the 7-methoxy derivative of the latter compound (cephamycin C), and deacetoxy cephalosporin C, as well as penicillin N (8, 9, 12, 16; M. Gorman, M. M. Hoehn, R. Nagarajan, L. D. Boeck, E. A. Presti, J. G. Whitney, and R. L. Hamill, Prog. Abstr. Intersci. Conf. Antimicrob. Agents Chemother., 11th, Atlantic City, N.J., abstr. 14, p. 7, 1971) . During an investigation of the metabolites produced by this culture, a pronounced /8-lactamase inhibitory activity was detected in the culture filtrate using a special bioassay procedure based on /8-lactamase inhibition (4) . The substance responsible for the /3-lactamase inhibitory activity was named clavulanic acid (4) and has been shown to have the structure given in Fig. 1 (10) . We describe below the detection, isolation, and preliminary information on the /3-lactamase-inhibitory properties of clavulanic acid.
MATERIALS AND METHODS
Cultural conditions for S. clavuligerus. S. clavuligerus ATCC 27064 (NRRL 3585) was grown at 26°C on agar slopes containing 1% Yeatex yeast extract, 1% glucose, and 2% Oxoid agar no. 3, pH 6.8. Mycelium and spores from the slope were used to inoculate flasks containing a seed stage medium consisting of (wt/vol) 1% malt extract (Oxoid), 1% bacteriological peptone (Oxoid), and 2% glycerol. The medium was made up using tap water and adjusted to pH 7.0 with sodium hydroxide solution. Inoculated flasks were shaken for 3 days at 26°C.
Production stage flasks containing the DAS medium were inoculated with 5% vegetative inoculum from the seed flasks. The DAS medium consisted of 2% dextrin, 1% Arkasoy 50 soyabean flour (British Arkady Co., Manchester, U.K.), 0.1% Scotasol dried distillers solubles (Thomas Borthwick Ltd, Glasgow, U.K.), and 0.01% FeSO4 7H2O in deionized water at a final pH of 7.0.
Media for both seed and production stages were dispensed in 100-ml volumes in 500-ml conical flasks which were closed with foam plugs and sterilized by autoclaving at 121°C for 15 min. Seed and production flasks were shaken at 26°C on a rotary shaker with 2-inch (5.08-cm) throw and a speed of 240 rpm.
The cultivation in stainless-steel fermentors was carried out using the DAS medium as described above, except that antifoam was added before steam sterilization. The antifoam was 10% Pluronic L81 (Ugine Kuhlmann Chemicals Ltd, London, U.K.) in soyabean oil and was added to give a final concentration of 0.05% (wt/vol). The seed fermentor containing 50 liters of medium was inoculated with 100 ml of a spore/mycelial suspension prepared by adding a sterile solution of 0.05% Triton X-100 in water to a Yeatex/glucose agar (see above) slope in a roux bottle grown for 10 days at 26°C. The 90-liter baffled seed fermentor was agitated by a 13-cm disk turbine impeller at 240 rpm. Sterile air was supplied at 50 liters/min, and the temperature was 26°C. After 72 h the seed fermentor was used to provide a 5% vegetative inoculum into 150 liters of DAS fermentation medium contained in a 300-liter baffled fermentor. This fermentor was stirred at 210 rpm using a 21-cm 852 7) until it gave about 75% hydrolysis of a 1-mg/ml solution of substrate (see Table 2 ) in 30 min at 37°C. Suitable dilutions of the clavulanic acid preparation were mixed with the /Blactamase solution and incubated at 37°C for 15 min because of the progressive nature of the inhibition.
A control with buffer in place of clavulanic acid preparation was also incubated. Substrate in pH 7.0 buffer was then added to both inhibitor and control reaction mixtures to give a final concentration of 1 mg/ml, and incubation at 37°C was continued for a further 30 min at 37°C. The residual substrate in each mixture was then estimated using the hydroxylamine assay (3), and the results were used to calculate the percentage of inhibition.
Sodium benzylpenicillin (Beecham) was used as a substrate except for the cephalosporinase-producing cultures P. aeruginosa A, E. coli JT410, and Enterobacter cloacae P99, where cephaloridine (Glaxo) was used. The concentration and assay methods were the same for the two substrates except that the reaction time with the hydroxylamine reagent was reduced from 10 to 3 min for cephaloridine to optimize color formation with the ferric reagent.
The I, for clavulanic acid is defined as the concentration giving 50% inhibition of the 8-lactamase as measured by the above procedure, I50 values being obtained from a plot of percentage of inhibition against inhibitor concentration.
Chromatography of clavulanic acid. Paper chromatography was carried out on 1-cm-wide paper strips of Whatman grade 1. The solvent systems described in the text were used in the descending fashion at 4°C. The position of clavulanic acid was located using the bioautographic method described below.
Thin-layer chromatography was carried out at 20°C using precoated, glass-backed, thin-layer plates (Merck silica gel 60). Clavulanic acid was detected by spraying with the TTC reagent, which consisted of equal volumes of 4% methanolic solution of 2,3,5-triphenyltetrazolium chloride and aqueous 1 N NaOH.
Special bioautographic detection method for clavulanic acid. Clavulanic acid was located on paper strip chromatograms by contacting the dried strips with agar containing benzylpenicillin and seeded with Klebsiella aerogenes A, a variant of K. aerogenes NCTC 418. Inoculum was prepared by growing this culture overnight in 2.5% Oxoid nutrient broth CM67 in a test tube at 28°C. A 300-ml amount of 4% blood agar base (Oxoid CM55) was cooled to 50°C after sterilization before addition of 0.8 ml of inoculum and 1 ml of 1.8 mg of sodium benzylpenicillin per ml (final concentration, 6 gg/ml). For 
RESULTS
Detection and isolation of clavulanic acid. S. clavuligerus ATCC 27064 was grown for 4 days in shaken conical flasks using the DAS medium. Samples of culture filtrate were tested for ,3-lactamase inhibitory activity and were found to give a mean inhibition of 56% at a final dilution of 1/2,500 against the R factor-mediated /8-lactamase of E. coli JT4.
The culture fluid was examined by paper chromatography, the location of 3-lactamaseinhibitory material being determined by a special bioautographic procedure based on the fact that the 83-lactamase of K. aerogenes is readily inhibited by clavulanic acid ( Table 2) .
The results in Fig. 2 In addition to the above procedure, clavulanic acid can also be detected on thin-layer chromatography plates by spraying with TTC reagent. It appears as a dark red spot after heating the sprayed chromatogram and has an Rf value of 0.44 when using a solvent system consisting of n-butanol-ethanol-water (4:1:5, vol/vol/vol, top phase).
To provide culture fluid for the isolation of clavulanic acid, S. clavuligerus was grown in a 300-liter fermentor containing 150 liters of the DAS medium for 4 days at 26°C, by which time the clavulanic acid titer was in the region of 150 to 200 ,ug/ml. Clavulanic acid was isolated as its sodium salt according to the procedure outlined in Fig. 3 . During the isolation the metabolite was followed using the enzyme inhibition assay with the /3-lactamase from E. coli JT4.
/8-Lactamase-inhibitory properties of clavulanic acid. The enzyme-inhibitory activity of sodium clavulanate against a range of 3-lactamases was determined by measuring the amount required to give 50% inhibition (I51) under the conditions of the test (see Materials ANTIMICROB. AGENTS CHEMOTHER. and Methods). For all of the f3-lactamase preparations it was found that the degree of inhibition of the f8-lactamase increased with time. An interaction time of 15 min was arbitrarily chosen for the determination of 150 values. The results given in Table 2 show that f8-lactamases from both gram-negative and gram-positive organisms are inhibited by very low concentrations of clavulanic acid. The enzymes not so readily inhibited under the test conditions were those with a predominantly cephalosporinase activity and the enzyme preparation from B. cereus, which contained both enzymes I and II. Enzymes that are well inhibited include those from clinically important organisms such as E. coli harboring the RTEM plasmid. This is exemplified in Table 2 by E. coli JT4, which was found to produce a 18-lactamase indistinguishable by isoelectric focusing and substrate profile from that found in E. coli K-12 pRTEM.
,B-Lactamase stability of clavulanic acid. Using paper chromatography and the special bioautographic detection method, no gross destruction of clavulanic acid was observed on incubation with those 13-lactamases that were less readily inhibited by clavulanic acid, such as those produced by P. aeruginosa A, E. coli JT410, and E. cloacae P99. The poor inhibitory activity against these 8-lactamases thus does not seem to be due to instability of the compound.
The activity of sodium clavulanate was the same against strains of bacteria that produced ,3-lactamase as against those that did not, reflecting the high stability of the compound to ,8-lactamase. Thus, the minimum inhibitory concentration for the /8-lactamase-producing Russell strain of S. aureus was the same as that against the Oxford strain, and the minimum inhibitory concentration for E. coli JT39, a potent 8-lactamase producer, was the same as that against E. coli NCTC 10418, an ampicillinsusceptible strain.
Enhancement of antibacterial activity of ,Blactamase-4abile antibiotics by clavulanic acid. When low levels of sodium clavulanate were added to 8-lactamase-labile compounds, the antibacterial spectrum of the labile compound could be widened to include many previously resistant (8-lactamase-producing organisms. Good correlations could be seen between enzyme inhibition data and antibacterial synergy tests. Data in Tables 2 and 3 show that where good inhibition was seen against isolated enzymes the organisms producing those enzymes were rendered susceptible to (8-lactam antibiotics in the presence-of sodium clavulanate. However, where inhibition was poor against isolated enzymes, such as the chromo- supplemented with cephamycin C (10 pi of 1 mg/ml). The solvent system was n-butanol-acetic acid-water (12:3:5, vol/vollvol), the paper was Whatman grade 1, and the loading was 15 ,ud ofsample. SF, Solvent front; 0, origin; CA, clavulanic acid; CC, cephamycin C. somal f3-lactamase of E. coli JT410, no significant change in minimum inhibitory concentration against this organism could be seen when sodium clavulanate was added to cephaloridine or ampicillin.
DISCUSSION
The property of /3-lactamase inhibition is well known for certain penicillins and cephalosporins (1). The inhibition exhibited by these compounds is usually restricted to a small num-VOL. 11, 1977 on November 1, 2017 by guest http://aac.asm.org/ Downloaded from ANTIMICROB. AGENTS CHEMOTHER. from Streptomyces gedanensis (7) and by Miyamura and Ochiai, also from a streptomycete (11) , but these were macromolecular substances.
Although clavulanic acid has weak broadspectrum antibacterial activity, its potential application is as an inhibitor of many clinically important 84-lactamases. It is thus possible, by adding clavulanic acid at low concentrations, to demonstrate marked improvement in the activity of 8-lactamase-labile penicillins and cephalosporins. This improvement of activity is very marked for strains of bacteria that owe their resistance to the production of (8-lactamase but only occurs where this enzyme is readily inhibited by clavulanic acid. It is hoped that clavulanic acid will provide a new aid to the treatment of infections caused by penicillin-and cephalosporin-resistant bacteria.
